Michael Reardon Download Headshot

Michael Reardon, MD

  • Houston Methodist cardiothoracic surgeon
  • Professor of cardiothoracic surgery, Weill Cornell Medical College
  • Allison Family Distinguished Chair of Cardiovascular Research at Houston Methodist Hospital 
Media Contact: Patti Muck , 713.851.4596

Michael Reardon, MD

Request Interview
Media Contact: Patti Muck , 713.851.4596

Areas of Expertise

  • Aortic surgery
  • Autotransplant
  • Blood conservation
  • Cardiac tumor surgery
  • Cardiac valve disease
  • Catheter based cardiac/aortic disease
  • Complex cardiac surgery
  • Transcatheter valve replacement (TAVR)

Credentials

BOARD CERTIFICATION
Vascular Surgery | American Board of Surgery
MEDICAL SCHOOL
Baylor College of Medicine, Houston, Texas | 1978
RESIDENCY
Baylor College of Medicine, Houston, Texas | 1983
FELLOWSHIP
Cardiothoracic Surgery | Texas Heart Institute, Houston, Texas | 1985

Publications

Intraprocedural Doppler and Invasive Hemodynamic Profiling Predict Clinical Outcomes After Mitral TEER
Zaid, S, Wessly, P, Hatab, T, Faza, N, Little, SH, Atkins, MD, Reardon, MJ, Kleiman, NS, Zoghbi, WA & Goel, SS 2024, , JACC: Cardiovascular Imaging, vol. 17, no. 4, pp. 454-456. https://doi.org/10.1016/j.jcmg.2023.10.013

Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair
Hatab, T, Samimi, S, Chaaya, RGB, Qamar, F, Kharsa, C, Wessly, P, Faza, N, Little, SH, Atkins, MD, Reardon, MJ, Kleiman, NS, Zoghbi, WA, Nagueh, SF, Zaid, S & Goel, SS 2024, , Journal of the American Heart Association, vol. 13, no. 5, e032784, pp. e032784. https://doi.org/10.1161/JAHA.123.032784

Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study
Bajwa, TK, Laham, RJ, Khabbaz, K, Dauerman, HL, Waksman, R, Weiss, E, Allaqaband, S, Badr, S, Caskey, M, Byrne, T, Applegate, RJ, Kon, ND, Li, S, Kleiman, N, Reardon, MJ, Chetcuti, SJ & Deeb, GM 2024, , American Journal of Cardiology, vol. 214, pp. 1-7. https://doi.org/10.1016/j.amjcard.2023.11.071

Characteristics and Outcomes of Patients Ineligible for Tricuspid Transcatheter Edge-to-Edge Repair
Hatab, T, Bou Chaaya, RG, Samimi, S, Qamar, F, Faza, N, Little, SH, Reardon, MJ, Kleiman, NS, Zoghbi, WA, Guha, A, Zaid, S & Goel, SS 2024, , Structural Heart, vol. 8, no. 2, 100235, pp. 100235. https://doi.org/10.1016/j.shj.2023.100235

National Variability in Pacemaker Implantation Rate Following TAVR: Insights From the STS/ACC TVT Registry
Vora, AN, Gada, H, Manandhar, P, Kosinski, A, Kirtane, A, Nazif, T, Reardon, M, Kodali, S, Cohen, DJ, Thourani, V, Sherwood, M, Julien, H & Vemulapalli, S 2024, , JACC: Cardiovascular Interventions, vol. 17, no. 3, pp. 391-401. https://doi.org/10.1016/j.jcin.2023.12.005

TAV-in-SAV or Redo SAVR: Are We Comparing Apples With Oranges?
Goel, SS & Reardon, MJ 2024, , American Journal of Cardiology, vol. 215, pp. 70-71. https://doi.org/10.1016/j.amjcard.2023.12.017

Understanding Treatment Preferences for Patients with Tricuspid Regurgitation
Iyer, V, Faza, NN, Pfeiffer, M, Kozak, M, Peterson, B, Wyler von Ballmoos, M, Mollenkopf, S, Mancilla, M, Latibeaudiere-Gardner, D & Reardon, MJ 2024, , MDM Policy and Practice, vol. 9, no. 1. https://doi.org/10.1177/23814683231225667

Evolut explant, Y annuloplasty, and surgical aortic valve replacement: Tips and tricks
Atkins, MD, He, YA & Reardon, MJ 2024, , Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.01.001

The 7 Pillars of Primary Cardiac Sarcoma Treatment
Atkins, MD, Ravi, V & Reardon, MJ 2024, , Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, vol. 19, no. 1, pp. 3-7. https://doi.org/10.1177/15569845241231794

Predictors and Trends of New Permanent Pacemaker Implantation: A Subanalysis of the International Navitor IDE Study
Sultan, I, Reardon, MJ, Søndergaard, L, Chehab, B, Smith, D, Walton, AS, Worthley, SG, Manoharan, G, Yong, G, Jilaihawi, H, Asch, F, Bates, N & Fontana, GP 2024, , Structural Heart. https://doi.org/10.1016/j.shj.2024.100293

1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results
Zahr, F, Song, HK, Chadderdon, S, Gada, H, Mumtaz, M, Byrne, T, Kirshner, M, Sharma, S, Kodali, S, George, I, Merhi, W, Yarboro, L, Sorajja, P, Bapat, V, Bajwa, T, Weiss, E, Thaden, JJ, Gearhart, E, Lim, S, Reardon, M, Adams, D, Mack, M & Leon, MB 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 23, pp. 2868-2879. https://doi.org/10.1016/j.jcin.2023.10.001

4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial
Evolut Low Risk Trial Investigators 2023, , Journal of the American College of Cardiology, vol. 82, no. 22, pp. 2163-2165. https://doi.org/10.1016/j.jacc.2023.09.813

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study
Tang, GHL, Spencer, J, Rogers, T, Grubb, KJ, Gleason, P, Gada, H, Mahoney, P, Dauerman, HL, Forrest, JK, Reardon, MJ, Blanke, P, Leipsic, JA, Abdel-Wahab, M, Attizzani, GF, Puri, R, Caskey, M, Chung, CJ, Chen, YH, Dudek, D, Allen, KB, Chhatriwalla, AK, Htun, WW, Blackman, DJ, Tarantini, G, Zhingre Sanchez, J, Schwartz, G, Popma, JJ & Sathananthan, J 2023, , Circulation: Cardiovascular Interventions, vol. 16, no. 11, pp. E013238. https://doi.org/10.1161/CIRCINTERVENTIONS.123.013238

Surgical Explantation of Failed Transcatheter Aortic Valve Replacement
EXPLANT-TAVR Investigators 2023, , Annals of Thoracic Surgery, vol. 116, no. 5, pp. 933-942. https://doi.org/10.1016/j.athoracsur.2023.05.036

Feasibility and Outcomes of Mitral Transcatheter Edge-To-Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification
Hatab, T, Bou Chaaya, RG, Zaid, S, Wessly, P, Satish, P, Villanueva, V, Faza, N, Little, SH, Atkins, MD, Reardon, MJ, Kleiman, NS, Zoghbi, WA & Goel, SS 2023, , Journal of the American Heart Association, vol. 12, no. 19, e031118, pp. e031118. https://doi.org/10.1161/JAHA.123.031118

TAV-in-TAV in Failed Homograft: Redo TAVI in a Patient With 3 Previous Sternotomies
Hatab, T, Zaid, S, Wessly, P, Reardon, MJ, Atkins, MD, Faza, N, Little, SH, Kleiman, NS & Goel, SS 2023, , JACC: Case Reports, vol. 22, 101973, pp. 101973. https://doi.org/10.1016/j.jaccas.2023.101973

Reply: Concerns Regarding the Report of 3-Year Outcomes of the Evolut Low Risk Trial
Forrest, JK & Reardon, MJ 2023, , Journal of the American College of Cardiology, vol. 82, no. 12, pp. e103. https://doi.org/10.1016/j.jacc.2023.06.042

Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial
Zimmermann, FM, Ding, VY, Pijls, NHJ, Piroth, Z, Van Straten, AHM, Szekely, L, Davidavicius, G, Kalinauskas, G, Mansour, S, Kharbanda, R, Östlund-Papadogeorgos, N, Aminian, A, Oldroyd, KG, Al-Attar, N, Jagic, N, Dambrink, JHE, Kala, P, Angeras, O, Maccarthy, P, Wendler, O, Casselman, F, Witt, N, Mavromatis, K, Miner, SES, Sarma, J, Engstrøm, T, Christiansen, EH, Tonino, PAL, Reardon, MJ, Otsuki, H, Kobayashi, Y, Hlatky, MA, Mahaffey, KW, Desai, M, Woo, YJ, Yeung, AC, De Bruyne, B & Fearon, WF 2023, , Circulation, vol. 148, no. 12, pp. 950-958. https://doi.org/10.1161/CIRCULATIONAHA.123.065770

Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial
FAME 3 Trial Investigators 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 17, pp. 2112-2119. https://doi.org/10.1016/j.jcin.2023.06.023

Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)
van Bergeijk, KH, Wykrzykowska, JJ, van Mieghem, NM, Windecker, S, Sondergaard, L, Gada, H, Li, S, Hanson, T, Deeb, GM, Voors, AA & Reardon, MJ 2023, , American Journal of Cardiology, vol. 200, pp. 78-86. https://doi.org/10.1016/j.amjcard.2023.05.036

Languages

  • English